Background: Pulmonary hypertension (PH) impairs quality of life, exercise performance and survival. Simple measures to monitor the disease are needed. Objectives: We tested whether actigraphy by a wrist-worn device in the patient's home reflects disease severity in PH patients. Methods: Twenty-three outpatients with pulmonary arterial and chronic thromboembolic PH (15 females), functional classes II-IV, underwent clinical examination and actigraphy over 2 weeks while pursuing their usual life at home. Actigraphies were correlated with clinical data and mean pulmonary artery pressure (mPAP). Deaths, lung transplantations and pulmonary endarterectomy were recorded over 4 years. Results: Actigraphies revealed a mean ± SD daytime activity duration of 14:57 ± 1:14 h with 146 ± 125 activity counts/min. Very severely impaired patients (mPAP 50 ± 7 mm Hg) were inactive for longer periods at night (8:25 ± 1:18 h) and less active during the day (54 ± 44 counts/min) when compared to modestly impaired patients (mPAP 33 ± 7 mm Hg; inactive at night for 6:58 ± 0:39 h; daytime activity 229 ± 148 counts/min, p < 0.05 in all instances). Out of 19 patients followed for 4 years, 5 died and 1 received a lung transplantation. Kaplan-Meier analysis revealed a shorter survival without lung transplantation in patients with a duration of daytime activity of <15 h/day than those with >15 h/day duration (log rank, p = 0.026). Conclusion: A long nocturnal rest and reduced daytime activity recorded by actigraphy are associated with severe hemodynamic impairment and reduced survival in patients with PH. Therefore, wrist actigraphy performed during everyday life in the patient's home holds promise as a simple tool for the assessment of disease severity and prognosis in patients with PH.

Keywords:
Pulmonary hypertension, Actigraphy, Mean pulmonary artery pressure
1.
Simonneau G, Robbins IM, Beghetti M, et al: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
2.
Jais X, D'Armini AM, Jansa P, et al: Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008;52:2127-2134.
3.
Barst RJ, Gibbs JS, Ghofrani HA, et al: Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S78-S84.
4.
Galie N, Hoeper MM, Humbert M, et al: Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
5.
Ulrich S, Speich R, Domenighetti G, et al: Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss Med Wkly 2007;137:573-580.
6.
Bonderman D, Nowotny R, Skoro-Sajer N, et al: Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2599-2603.
7.
Dartevelle P, Fadel E, Mussot S, et al: Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-648.
8.
Keogh AM, Mayer E, Benza RL, et al: Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol 2009;54:S67-S77.
9.
Ancoli-Israel S, Cole R, Alessi C, et al: The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003;26:342-392.
10.
Hastings PC, Vazir A, O'Driscoll DM, et al: Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients. Eur Respir J 2006;27:748-755.
11.
Kario K, Schwartz JE, Pickering TG: Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension 1999;34:685-691.
12.
Otake M, Miyata S, Noda A, et al: Monitoring sleep-wake rhythm with actigraphy in patients on continuous positive airway pressure therapy. Respiration 2011;82:136-141.
13.
Grunig E, Ehlken N, Ghofrani A, et al: Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration 2011;81:394-401.
14.
Ulrich S, Fischler M, Speich R, et al: Sleep-related breathing disorders in patients with pulmonary hypertension. Chest 2008;133:1375-1380.
15.
Cenedese E, Speich R, Dorschner L, et al: Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 2006;28:808-815.
16.
Ware JE, Snow KK, Kosinski M, et al: SF-36 Health Survey: manual and interpretation guide. Boston, The Health Institute, New England Medical Center, 1993.
17.
Bloch KE, Schoch OD, Zhang JN, et al: German version of the Epworth Sleepiness Scale. Respiration 1999;66:440-447.
18.
Galie N, Manes A, Uguccioni L, et al: Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest 1998;114:184S-194S.
19.
Grachtrup S, Brugel M, Pankau H, et al: Exercise dependence of N-terminal pro-brain natriuretic peptide in patients with precapillary pulmonary hypertension. Respiration 2012;84:454-460.
20.
Ulrich S, Huber LC, Fischler M, et al: Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension. Respiration 2011;81:211-216.
21.
McLaughlin VV, Badesch DB, Delcroix M, et al: End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S97-S107.
22.
Littner M, Kushida CA, Anderson WM, et al: Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 2003;26:337-341.
23.
Sadeh A, Acebo C: The role of actigraphy in sleep medicine. Sleep Med Rev 2002;6:113-124.
24.
Bauldoff GS, Ryan-Wenger NA, Diaz PT: Wrist actigraphy validation of exercise movement in COPD. West J Nurs Res 2007;29:789-802.
25.
Long AC, Palermo TM, Manees AM: Brief report: using actigraphy to compare physical activity levels in adolescents with chronic pain and healthy adolescents. J Pediatr Psychol 2008;33:660-665.
26.
Balboa-Castillo T, Leon-Munoz LM, Graciani A, et al: Longitudinal association of physical activity and sedentary behavior during leisure time with health-related quality of life in community-dwelling older adults. Health Qual Life Outcomes 2011;9:47.
27.
Vallance JK, Lavallee CM, Culos-Reed NS, et al: Physical activity is associated with clinically important differences in health-related quality of life among rural and small-town breast cancer survivors. Support Care Cancer 2012;20:1079-1087.
28.
Potter R, Ellard D, Rees K, et al: A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia. Int J Geriatr Psychiatry 2011;26:1000-1011.
29.
Adeniyi AF, Okafor NC, Adeniyi CY: Depression and physical activity in a sample of Nigerian adolescents: levels, relationships and predictors. Child Adolesc Psychiatry Ment Health 2011;5:16.
30.
Hecht A, Ma S, Porszasz J, et al: Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD. COPD 2009;6:121-129.
31.
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
32.
Guyatt GH, Sullivan MJ, Thompson PJ, et al: The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
33.
McKenna SP, Doughty N, Meads DM, et al: The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res 2006;15:103-115.
34.
Manini TM, Everhart JE, Patel KV, et al: Daily activity energy expenditure and mortality among older adults. JAMA 2006;296:171-179.
35.
Walsh JT, Charlesworth A, Andrews R, et al: Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Cardiol 1997;79:1364-1369.
36.
Schulz R, Baseler G, Ghofrani HA, et al: Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J 2002;19:658-663.
37.
Hildenbrand FF, Bloch KE, Speich R, Ulrich S: Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Respiration 2012; 84:477-484.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.